Management and prevention of corneal graft rejection
The management of an episode of corneal graft rejection (CGR) is primarily by corticosteroids. Immunomodulators are useful for long-term immunosuppression and in dealing with cases of high-risk (HR) corneal grafts. The classical signs of CGR following penetrating keratoplasty (PKP) include rejection...
| Автори: | , , , , , |
|---|---|
| Формат: | Стаття |
| Мова: | English |
| Опубліковано: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Серія: | Indian Journal of Ophthalmology |
| Предмети: | |
| Онлайн доступ: | http://www.ijo.in/article.asp?issn=0301-4738;year=2023;volume=71;issue=9;spage=3149;epage=3159;aulast=Mandal |
| Резюме: | The management of an episode of corneal graft rejection (CGR) is primarily by corticosteroids. Immunomodulators are useful for long-term immunosuppression and in dealing with cases of high-risk (HR) corneal grafts. The classical signs of CGR following penetrating keratoplasty (PKP) include rejection line, anterior chamber (AC) reaction, and graft edema. However, these signs may be absent or subtle in cases of endothelial keratoplasty (EK). Prevention of an episode of graft rejection is of utmost importance as it can reduce the need for donor cornea significantly. In our previous article (IJO_2866_22), we had discussed about the immunopathogenesis of CGR. In this review article, we aim to discuss the various clinical aspects and management of CGR. |
|---|---|
| ISSN: | 0301-4738 1998-3689 |